Bevacizumab and its use in epithelial ovarian cancer

ISSN： 1479-6694

Source： Future Oncology, Vol.7, Iss.3, 2011-03, pp. : 365-379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab: A Review of its Use in Advanced Colorectal Cancer, Breast Cancer, and NSCLC

By Lyseng-Williamson Katherine A. Robinson Dean M.

American Journal of Cancer, Vol. 5, Iss. 1, 2006-01 ,pp. : 43-60

Adis International

Access to resources Recommend Favorite

The Use of Paclitaxel and Cisplatin in a Patient with Epithelial Ovarian Cancer and Human Immunodeficiency Virus

By Knox S.N. Robinson J.B. Im D.D. Logan L. Rosenshein N.B.

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 118-122

Elsevier

Access to resources Recommend Favorite

Bevacizumab treatment and quality of life in advanced ovarian cancer

By Canevari Silvana Raspagliesi Francesco Lorusso Domenica

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 951-954

Future Medicine

Access to resources Recommend Favorite

Splenectomy in Recurrent Epithelial Ovarian Cancer

By Gemignani M.L. Chi D.S. Gurin C.C. Curtin J.P. Barakat R.R.

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 407-410

Elsevier

Access to resources Recommend Favorite

Epithelial ovarian cancer: A case report

Experimental and Therapeutic Medicine, Vol. 8, Iss. 5, 2014-01 ,pp. : 1535-1538

Spandidos Publications

Access to resources Recommend Favorite